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ABSTRACT
A novel series of thiophene derived Schiff bases and their transition metal- [Co(II), Cu(II), Zn(II), Ni(II)] based
compounds are reported. The Schiff bases act as tridentate ligands toward metal ions via azomethine-N,
deprotonated-N of ammine substituents and S-atom of thienyl moiety. The synthesized ligands along with
their metal complexes were screened for their in vitro antibacterial activity against six bacterial pathogens
(Escherichia coli, Shigella flexneri, Pseudomonas aeruginosa, Salmonella typhi, Staphylococcus aureus and
Bacillus subtilis) and for antifungal activity against six fungal pathogens (Trichophytonlongifusus, Candida
albicans, Aspergillus flavus, Microsporum canis, Fusarium solani and Candida glabrata). The results of anti-
microbial studies revealed the free ligands to possess potential activity which significantly increased upon
chelation.
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The importance and application of Schiff bases has attracted an
enormous research interests in the synthesis of metal-based com-
pounds1–3. Many Schiff bases have been reported4 to possess
significant biological properties such as anti-microbial5, anti-bac-
terial6, anti-fungal7, anti-tumor8, anti-inflammatory9, anti-HIV10,
anti-convulsant11, anti-cancer12,13, anti-malarial14, antiviral15 and as
an analgesic16. Due to significant structural properties and applica-
tions of metals-based compounds in bioactivities, we wish to
report a new class of antibacterial and antifungal thiophene
derived Schiff bases, N-[(1E)-1-(thiophen-2-yl)ethylidene]ethane-1,
2-diamine (L1), N-[(1E)-1-(thiophen-2-yl) ethylidene]propane-1,
3-diamine (L2) and N-[(1E)-1-(thiophen-2-yl) ethylidene]butane-1,4-
diamine (L3) (Scheme 1) and their Co(II), Cu(II), Ni(II) and Zn(II)
metal chelates (1)–(12) (Scheme 2). The synthesized Schiff bases
and their metal chelates have been screened for their bactericidal/
fungicidal activity against a number of bacterial/fungal strains and
results have been reported.
Experimental
Materials and methods
All the chemicals used were of analytical grades and purchased
from Sigma Aldrich and were used without further purification. All
ligand synthetic reactions were carried out in solvents that were
purified and dried before use, using standard literature methods.
Gallenkamp melting point apparatus was used for recording melt-
ing points. The infrared absorption spectra were recorded as KBr
pellets on Excalibur FTR-IR 4800MX spectrophotometer (Bio-Rad
Laboratories, Cambridge, MA) in the frequency range
200–4000 cm1. Elemental analysis was carried out on Perkin
Elmer. 1H and 13C NMR spectra were recorded on a Bruker
SpectrospinAvance400 DPX spectrometer using TMS as internal
standard and d6-DMSO as a solvent. Electron impact mass spectra
(EIMS) were recorded on JEOL MS Route instrument. UV–Vis spec-
tra were recorded on ultraviolet spectrometer-1700 in the fre-
quency range of 250–800 nm. Conductivity meter Jen way model
70 was used for measuring the conductivity of metal complexes
using 0.001 molar solutions in DMSO at room temperature.
A Stanton SM12/S Gouy balance was used to measure the mag-
netic susceptibility of the metal complexes at room temperature
using mercury acetate ligand as a standard. In vitro antibacterial
and antifungal properties were studied at HEJ Research Institute of
Chemistry, International Center for Chemical Sciences, University
of Karachi, Pakistan.
Synthesis of ligands
1-(Thiophene-2-yl)ethanone (0.002 M, 0.25 g) dissolved in ethanol
(20mL) was added to a stirred solution of ethane-1,2-diamine/pro-
pane-1,3-diamine/butane-1,4-diamine respectively in ethanol
(15mL) in an equimolar ratio followed by 2–3 drops of acetic acid.
The reaction mixture was stirred for 8 h with continuous monitor-
ing through TLC and then kept overnight at room temperature.
The solid crystallized product was obtained which was filtered,
washed with ethanol and dried. It was recrystallized in a mixture
of hot ethanol:acetone (1:1).
N-[(1E)-1-(thiophen-2-yl)ethylidene]ethane-1,2-diamine (L1)
Yield: (1.63 g, 64%); mp140 C; color (off white); IR (KBr, cm1):
3365 (NH2),1683 (C¼N), 1607 (C¼C), 1065 (C–N) and 882 (C–S);
1H NMR (ppm d6-DMSO): d 2.35 (s, CH3), 3.06 (t, 2H), 3.71 (t, 2H),
5.75 (s, NH2), 7.05 (d, 1H, J¼ 8.5 Hz), 7.41 (dd, 1H, J¼ 8.5, 2.6 Hz),
7.60 (d, 1H, J¼ 2.6 Hz); 13C NMR (DMSO-d6): d 14.90 (CH3), 41.54,
54.18, 123.52, 130.93, 135.18, 137.32 and 156.15; mass spectrum
(ESI): [M]þ¼ 168.1. Anal. Calc. for C8H12N2S (168.26): C, 57.11;
H, 7.19; N, 16.65; S, 19.06. Found: C, 57.05; H 7.15; N, 16.60;
S, 19.01.
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N-[(1E)-1-(thiophen-2-yl)ethylidene]propane-1,2-diamine (L2)
Yield (1.55 g, 57%); mp 160 C; color (off white); IR (KBr, cm1): 3348
(NH2),1655 (C¼N), 1634 (C¼C), 1063 (C–N) and 887 (C–S); 1H NMR
(ppm d6-DMSO): d 2.31 (s, CH3), 2.55 (m, 2H), 3.01 (t, 2H), 3.65 (t, 2H),
5.70 (s, NH2), 7.02 (d, 1H, J¼ 8.5Hz), 7.38 (dd, 1H, J¼ 8.5, 2.6 Hz),
7.55 (d, 1H, J¼ 2.6 Hz); 13C NMR (DMSO-d6): d 14.87 (CH3), 40.54,
45.31, 55.19, 122.95, 130.22, 134.41, 136.54 and 155.86; mass spec-
trum (ESI): [M]þ¼ 182.2. Anal. Calc. for C9H14N2S (182.29): C, 59.30;
H, 7.74; N, 15.37; S, 17.59. Found: C, 59.23; H 7.70; N, 15.32; S, 17.55.
N-[(1E)-1-(thiophen-2-yl)ethylidene]butane-1,2-diamine (L3)
Yield (2.64 g, 74%); mp: 98 C, color (off white); IR (KBr, cm1):
3387 (NH2),1669 (C¼N), 1641 (C¼C), 1062 (C–N) and 889 (C–S); 1H
NMR (ppm d6-DMSO): d 2.33 (s, CH3), 2.46 (m, 2H), 2.65 (m, 2H),
3.03 (t, 2H), 3.70 (t, 2H), 5.75 (s, NH2), 7.04 (d, 1H, J¼ 8.5 Hz), 7.40
(dd, 1H, J¼ 8.5, 2.6 Hz), 7.58 (d, 1H, J¼ 2.6 Hz); 13C NMR (DMSO-
d6): d 14.90 (CH3), 33.67, 35.25, 41.54, 54.18, 123.45, 130.19, 134.98,
137.18 and 156.09; mass spectrum (ESI): [M]þ¼ 196.1. Anal. Calc.
for C10H16N2S (196.31): C, 61.18; H, 8.21; N, 14.27; S, 16.33. Found:
C, 61.11; H, 8.17; N, 14.21; S, 16.29.
Synthesis of metal(II) complexes
All metal complexes were prepared according to the standard pro-
cedure in which ethanol solution (15mL) of the respective
metal(II) salt (5mmol) was added respectively into a refluxed etha-
nol solution (30mL) of the Schiff base ligand (10mmol). The mix-
ture was refluxed for 3 h, during which a precipitated product was
formed. It was then cooled to room temperature, filtered, washed
with hot ethanol and finally with diethyl ether. The precipitated
product thus obtained was dried and crystallized in a mixture of
hot aqueous methanol (1:2) to obtain TLC pure product.
NMR data of the Zn(II) complexes
[Zn(L1)2] (4):
1HNMR (DMSO-d6, d, ppm): 2.42 (s, CH3), 3.16 (t, 2H),
3.82 (t, 2H), 5.89 (s, NH2), 7.15 (d, 1H, J¼ 8.5 Hz), 7.48 (dd, 1H,
J¼ 8.5, 2.6 Hz), 7.75 (d, 1H, J¼ 2.6 Hz); 13CNMR (DMSO-d6): d 14.98
(CH3), 42.26, 55.05, 124.64, 131.65, 135.89, 137.96 and 157.25.
[Zn(L2)2] (8):
1HNMR (DMSO-d6, d, ppm): 2.38 (s, CH3), 2.70 (m,
2H), 3.28 (t, 2H), 3.83 (t, 2H), 5.99 (s, NH2), 7.28 (d, 1H, J¼ 8.5 Hz),
7.56 (dd, 1H, J¼ 8.5, 2.6 Hz), 7.76 (d, 1H, J¼ 2.6 Hz); 13CNMR
(DMSO-d6): d 14.98 (CH3), 41.82, 46.26, 56.15, 123.89, 130.22,
134.41, 136.54 and 157.16.
[Zn(L3)2] (12):
1HNMR (DMSO-d6, d, ppm): 2.42 (s, CH3), 2.52
(m, 2H), 2.70 (m, 2H), 3.15 (t, 2H), 3.84 (t, 2H), 5.90 (s, NH2), 7.17
(d, 1H, J¼ 8.5 Hz), 7.51 (dd, 1H, J¼ 8.5, 2.6 Hz), 7.73 (d, 1H,
J¼ 2.6 Hz); 13CNMR (DMSO-d6): d 15.39 (CH3), 33.76, 35.33, 42.6254,
55.11, 124.55, 130.93, 135.63, 137.74 and 157.14.
Biological activity
Antibacterial activity (in vitro)
Agar-well diffusion method17 was used to test antimicrobial activ-
ity and toxicity of all the newly synthesized acetyl thiophene
derived Schiff bases (L1)–(L3) and their resulting metal (II) com-
plexes (1)–(12) against four gram-negative (E. coli, S. flexneri, P.
aeruginosa and S. typhi) and two gram-positive (S. aureus, B. subti-
lis) bacterial strains (Figure 1). The wells (6mm in diameter) were
dug in the media with the help of a sterile metallic borer with
centers at least 24mm apart. Bacterial inoculums after 6–8 h of
growth approximately having104–106 colony forming units (CFU)/
mL were used. The recommended concentration of the test sam-
ple (1mg/mL in DMSO) was introduced in the respective wells.
Other wells supplemented with DMSO and reference antibacterial
drug (imipenem) served as a negative and positive control,
respectively. The plates were incubated at 37 C for 24 h. The activ-
ity was determined by the measurement of the diameter of zones
which showed complete inhibition (mm). Separate studies of
DMSO were carried out to rule out any role of DMSO in antibac-
terial activities but expectedly it showed no activity against any of
the bacterial strains used in this study.
Antifungal activity (in vitro)
Antifungal activities of all compounds were studied17against six
fungal strains (T. longifusus, C. albicans, A. flavus, M. canis, F. solani
Scheme 1: Preparation of Schiff bases.
Scheme 2: Co(II), Ni(II), Cu(II) and Zn(II) metal complexes (1)–(12) with (L1)–(L3).
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and C. glabrata). Sabouraud dextrose agar (Oxoid, Hampshire,
England) was seeded with 105 (cfu) mL1 fungal spore suspen-
sions and transferred to petri plates. Discs soaked in 20mL
(200 lg/mL in DMSO) of the compounds were placed at different
positions on the agar surface. The plates were incubated
at 32 C for 7 d. The results were recorded as a percentage of
inhibition and compared with standard drugs miconazole and
amphotericin B.
Minimum inhibitory concentration (MIC)
Compounds showing promising antibacterial (>80%) activity were
selected for minimum inhibitory concentration (MIC) studies18.
Disc diffusion method was applied to determine minimum inhibi-
tory concentration by preparing discs containing 10, 25, 50 and
100 lg mL1 concentrations of the compounds along with stand-
ards at the same concentrations.
Results and discussion
Chemistry
The condensation reaction of 1-(thiophene-2-yl) ethanone with
ethane-1,2-diamine, propane-1,3-diamine and butane-1,4-diami-
neyieldedthree Schiff bases (L1)–(L3) (Scheme 1) in an equimolar
ratio. The synthesized ligands were stable in air and moisture.
They were colorless crystalline solids showing their melting points
in the range of 98–160 C. All of them were soluble in methanol,
ethanol, dioxane, DMSO and DMF. These ligands exhibited their
tridentate character and reacted readily with Co(II), Cu(II), Ni(II)
and Zn(II) metals as their in ethanol to form their respective
metal(II) complexes (Scheme 2).
All the synthesized metal(II) complexes were microcrystalline in
nature and were intensely colored except the Zn(II) complexes,
which were off-white in color. The metal(II) complexes decom-
posed without melting and were soluble in ethanol, methanol,
DMSO and DMF. The analytical data of the complexes indicated a
1:2 (metal: ligand) stoichiometry. The spectral data as well as elem-
ental analysis of the synthesized ligands and their metal(II) com-
plexes were in good agreement with their structure, indicating the
high purity of all the compounds.
IR spectra
The IR spectra of Schiff bases reveal presence of the active donor
sites like azomethine-N (–C¼N), aliphatic ammine (–NH2) and C–S
moieties which are responsible for chelation with the transition
metal atoms. The Schiff bases (L1)–(L3) possessed typical
azomethine (–C¼N) stretching19 at 1655–1683 cm1, hence con-
firming production of the required product. One of each amino
group remained unchanged during condensation reaction and
their bands were also observed at 3348–3387 cm1, respectively,
as they did not take part in the reaction. All the ligands showed
C–N and C–S stretching20 at 1062–1065 and 882–889 cm1,
respectively. The IR spectral comparison of the Schiff bases
(L1)–(L3) with their metal(II) complexes (1)–(12) indicated that the
Schiff bases were principally coordinated to the metal(II) ions in a
tridentate manner. The vibrations of azomethine group in all the
metal complexes (1)–(12) shifted to lower frequency (10–20 cm1)
at 1638–1668 cm1 demonstrating the coordination of the azome-
thine nitrogen21 with the metal(II) atoms. Shifting of (–NH2), C–N
and C–S vibrations at 3348–3387, 1062–1065 and 882–889 cm1 to
3330–3375, 1040–1045 and 868–877 cm1, respectively, supported
the coordination of ligands with metal atoms. Appearance of the
new bands at 543–580 and 460–471 cm1 could be assigned22 to
v(M–N) and v(M–S) vibrations in their metal complexes, which
were actually absent in their ligands also confirmed the mode of
chelation. Therefore, these clues supported the evidence of the
participation of azomethine-N, thienyl-S in the coordination. This
data provides good evidence for the coordination of the metal(II)
ions to the synthesized Schiff base ligands.
1HNMR spectra
1H NMR spectra of the Schiff bases (L1)–(L3) and their diamag-
netic Zn(II) complexes were recorded in DMSO-d6 and spectral
data is provided in the experimental section. The 1H NMR spectra
of Schiff basesdisplayed23 characteristic amino (NH2) protons at
5.70–5.75 ppm as a singlet which provided evidence for the con-
densation of only one amino group of diammines with acetyl thi-
ophene. All of the ligands (L1)–(L3) showed methyl (CH3) protons
at 2.31–2.35 ppm as a singlet and thienyl protons at
7.02–7.60 ppm as a doublet and double of doublet. The methy-
lene (CH2) protons of ligand (L
1) were observed at
3.06–3.71 ppm as a triplet, propylene protons of ligand (L2) were
found at 2.55–3.65 ppm as a triplet and multiplet. Similarly, buty-
lene protons of ligand (L3) appeared at 2.46–3.70 ppm as a trip-
let and multiplet. The complexation of the azomethine (C¼N)
nitrogen was proven by the downfield shifting of the methyl
protons in their Zn(II) complexes, which could be attributed to
the discharging of electronic cloud toward the Zn(II) ion. All pro-
tons underwent downfield shift by 0.06–0.18 ppm due to the
increased conjugation on coordination with the zinc metal atom.
Largely, the number of protons calculated from the integration
curves24 and obtained values of the CHN analysis agreed were
found to be in agreement.
Figure 1. Comparison of antibacterial activity of Schiff bases versus metal(II) complexes.
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13C NMR spectra
The 13CNMR spectra of the Schiff bases and their diamagnetic
Zn(II) complexes were recorded in DMSO-d6 and data is reported
along with their possible assignments in the experimental section
and all the carbons were found in their expected regions. The
13CNMR spectra of the Schiff bases (L1)–(L3) displayed methyl car-
bons at 14.87–14.90 ppm. Similarly, carbons of ethylene, propylene
and butylene were found at 33.67–55.19. However, the distinctive
azomethine (C¼N) carbons were observed at 155.86–156.15 ppm.
The thienyl carbons of hetero-aromatic rings were observed at
122.95–137.32 ppm. Downfield shifting of the azomethine carbons
were found in the uncomplexed Schiff bases from
155.86–156.15 to 157.14–157.25 ppm in their Zn(II) complexes,
which can be attributed to the shifting of electronic density
toward the Zn(II) ion. Similarly, all carbons of methylene, ethylene,
propylene, butylene groups and aromatic rings being near to the
coordination sites also showed downfield shifting by 0.6–1.3 ppm
due to the increased conjugation and coordination with the metal
atoms. The downfield shifting also confirmed the coordination of
the azomethine to the zinc metal atom. Moreover, the presence of
the number of carbons is well in agreement with the expected
values from the literature24. Furthermore, the conclusions drawn
from these studies present further support to the modes of bond-
ing discussed in their IR and 1H NMR spectra.
Mass spectra
The mass fragmentation pattern of the ligands (L1)–(L3) followed
the cleavage of C¼N, C–N, N–H, C–C, C¼C and C–S bonds. The
mass spectral data and the most stable fragmentation values of
the ligands were depicted in the experimental section. All the
ligands showed pronounced molecular ion peaks. The mass spec-
tra of ligand (L1) displayed a molecular ion peak at m/z 168.1
(calc. 168.26) of [C8H12N2S]
þ, which loses a methyl group (CH3) as
a radical to give the most stable fragment at m/z 153 of
[C7H9N2S]
þ. Similarly, the molecular ion peak of ligand (L2) was
observed at m/z 182.2 (calc. 182.29) of fragment [C9H14N2S]
þ and
most stable fragment [C8H11N2S]
þ was found at m/z 167. In the
same way, the molecular ion peak [C10H16N2S]
þ of ligand (L3)
appeared at 196.2 (calc. 196.31) and its base peak [C9H13N2S]
þwas
observed at m/z 181. The mass spectral data of the Schiff bases
strongly confirmed the best possible structure of ligands and also
their bonding pattern.
Molar conductances and magnetic measurements
The molar conductance of the metal complexes was studied when
dissolved in DMSO. The data of molar conductance was
(86.8–65.2 ohm1 cm2 mol1) found to be in the range which indi-
cated the electrolytic25 nature of the complexes. The magnetic
moment (B.M.) values of all the metal(II) complexes (1)–(12) were
measured at room temperature. The Co(II), Ni(II) and Cu(II) com-
plexes were found to be paramagnetic and their magnetic suscep-
tibilities were 4.2–4.5, 3.1–3.4 and 2.2–2.5 B.M., respectively, thus
indicative of one, two and three unpaired electron suggesting
octahedral26,27 geometry. All the Zn(II) complexes were found to
bediamagnetic28 in nature (Table 1).
Electronic spectra
The electronic spectral values of the metal(II) complexes are
recorded in Table 2. The electronic spectra of Co(II) complexes dis-
played well resolved absorption bands in the region 7590–7645,
17 490–17 642 and 23 134–23 252 cm1 which may be assigned
to 4T1g ! 4T2g(F), 4T1g ! 4A2g(F) and 4T1g ! 4Tg(P) transitions,
respectively29. A high-energy band at 29 858–30 030 cm1 was
due to metal ! ligand charge transfer. These bands suggest
Table 1. Physical measurements and analytical data of metal(II) complexes (1)–(12).
Elemental analysis (%) Calc. (found)
No. Structure Yield (%) MW/formula M.P. (C) C H N M
(1) [Co(L1)2] 75 [466.36] C16H24N4S2Cl2Co 311–312 41.21 (41.14) 5.19 (5.16) 12.01 (11.96) 12.64 (12.60)
(2) [Ni(L1)2] 72 [466.12] C16H24N4S2Cl2Ni 315–316 41.23 (41.17) 5.19 (5.15) 12.01 (11.97) 12.59 (12.55)
(3) [Cu(L1)2] 68 [470.97] C16H24N4S2Cl2Cu 300–301 40.80 (40.74) 5.14 (5.11) 11.90 (11.85) 13.49 (13.44)
(4) [Zn(L1)2] 65 [472.81] C16H24N4S2Cl2Zn 305–306 40.64 (40.58) 5.12 (5.09) 11.85 (11.81) 13.56 (13.50)
(5) [Co(L2)2] 69 [494.41] C18H28N4S2Cl2Co 309–311 43.73 (43.66) 5.71 (5.68) 11.33 (11.27) 11.92 (11.88)
(6) [Ni(L2)2] 70 [494.17] C18H28N4S2Cl2Ni 305–307 43.75 (43.70) 5.71 (5.66) 11.34 (11.30) 11.88 (11.82)
(7) [Cu(L2)2] 75 [499.02] C18H28N4S2Cl2Cu 321–322 43.32 (43.28) 5.66 (5.63) 11.23 (11.19) 12.73 (12.68)
(8) [Zn(L2)2] 72 [500.87] C18H28N4S2Cl2Zn 319–321 43.16 (43.08) 5.63 (5.60) 11.19 (11.15) 12.80 (11.75)
(9) [Co(L3)2] 78 [522.46] C20H32N4S2Cl2Co 305–306 45.98 (45.91) 6.17 (6.13) 10.72 (10.68) 11.28 (11.23)
(10) [Ni(L3)2] 68 [522.22] C20H32N4S2Cl2Ni 325–326 46.00 (46.94) 6.18 (6.15) 10.73 (10.68) 11.24 (11.18)
(11) [Cu(L3)2] 65 [527.08] C20H32N4S2Cl2Cu 329–331 45.57 (45.51) 6.12 (6.08) 10.63 (10.58) 12.06 (12.02)
(12) [Zn(L3)2] 71 [528.92] C20H32N4S2Cl2Zn 327–329 45.42 (45.35) 6.10 (6.06) 10.59 (10.55) 12.36 (12.30)
Table 2. Conductivity, magnetic and spectral data of metal(II) complexes (1)–(12).
No. XM (X
1 cm2 mol1) B.M. leff km (cm
1) IR (cm1)
(1) 88.3 4.2 7622, 17 490, 23 134, 29 858 3348 (NH2), 1663 (C¼N), 1045 (C–N), 868 (C–S), 574 (M–N), 462 (M–S)
(2) 88.9 3.1 9875, 15 263, 25 743, 29 586 3350 (N–H), 1665 (C¼N), 1044 (C–N), 870 (C–S), 565 (M–N), 460 (M–S)
(3) 92.7 2.2 15 713, 19 415, 29 967 3352 (NH2), 1666 (C¼N), 1045 (C–N), 869 (C–S), 547 (M–N), 468 (M–S)
(4) 87.4 Dia 29 926 3355 (NH2),1668 (C¼N), 1043 (C–N), 872 (C–S), 548 (M–N), 470 (M–S)
(5) 93.1 4.3 7590, 17 587, 23 252, 30 030 3330 (NH2),1645 (C¼N), 1043 (C–N), 875 (C–S), 576 (M–N), 466 (M–S)
(6) 86.8 3.2 9939, 15 379, 25 865, 29 690 3336 (NH2),1642 (C¼N), 1045 (C–N), 874 (C–S),561 (M–N), 465 (M–S)
(7) 92.3 2.4 15 681, 19 617, 29 935 3332 (NH2),1638 (C¼N), 1044 (C–N), 873 (C–S), 573 (M–N), 463 (M–S)
(8) 87.0 Dia 29 898 3335 (NH2),1640 (C¼N), 1045 (C–N), 871 (C–S), 546 (M–N), 470 (M–S)
(9) 91.2 4.5 7645, 17 642, 23 162, 29 961 3374 (NH2), 1649 (C¼N), 1040 (C–N), 877 (C–S), 580 (M–N), 469 (M–S)
(10) 95.2 3.4 9914, 15 290, 25 812, 29 635 3375 (NH2), 1656 (C¼N), 1041 (C–N), 876 (C–S), 568 (M–N), 463 (M–S)
(11) 90.5 2.5 15 802, 19 585, 29 892 3370 (NH2), 1652 (C¼N), 1042 (C–N), 875 (C–S), 548 (M–N), 468 (M–S)
(12) 94.8 Dia 29 902 3372 (NH2), 1654 (C¼N), 1043 (C–N), 874 (C–S), 543 (M–N), 471 (M–S)
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presence of a high-spin octahedral geometry around the Co(II) ion.
The electronic spectral data of Ni(II) complexes exhibited30 the
d–d bands in the region of 9875–9939, 15 263–15 379 and 25
743–25 865 cm1, which could be assigned to the spin allowed
transitions of 3A2g(F) ! 3T2g(F), 3A2g(F) ! 3T1g(F) and 3A2g(F) !
3T1g(P), respectively, consistent with the octahedral geometry. A
high-intensity band was also observed at 29 585–29 690 cm1 due
to metal ! ligand charge transfer. The spectra of Cu(II) complexes
demonstrated two weaker bandsat 15 681–15 802 and 19 415–19
617 cm1, which represent the transitions 2B1g ! 2A1g and 2B1g !
2Eg, respectively, indicating their octahedral geometry. The high-
energy band was also observed at 29 892–29 967 cm1 assigned
to the metal ! ligand charge transfer. On the basis of electronic
spectra, octahedral geometry around the Cu(II) ion was sug-
gested31. The Zn(II) complexes did not show any d–d transition
thus showing diamagnetic nature and their spectra were domi-
nated only by a charge transfer band32 at 29 898–28 926 cm1.
Biological studies
Antibacterial activity (in vitro)
The synthesized novel Schiff bases (L1)–(L3) and their metal(II)
complexes (1)–(12) were screened for their in vitro antibacterial
activity against Escherichia coli (E. coli), Pseudomonas aeruginosa (P.
aeruginosa), Salmonella typhi (S. typhi), Shigella flexneri (S. flexneri),
Staphylococcus aureus (S. aureus) and Bacillus subtilis (B. subtilis)
according to the standard procedure17and results are depicted in
Table 3. The results were compared with imipenem, a standard
broad-spectrum b lactam antibiotic. Ligand (L1) exhibited signifi-
cant (16mm) activity against S. flexneri and B. subtilis and rest of
the strains showed moderate (10–13mm) activity. Ligand (L2) dis-
played weaker (9mm) activity against S. flexneri and
Staphylococcus aureus, and against rest of the strains demon-
strated moderate (10–13mm) activity. Ligand (L3) also demon-
strated significant (16–19mm) activity against P. aeruginosa and S.
flexneri, moderate (13–15mm) activity against E. coli and S. typhi
and weaker activity (8–9mm) against the remaining two strains.
The transition metal complexes (1), (3), (4), (6), (10) and (12)
showed overall significant (16–25mm) activity against all the
strains. The complexes (2), (7) and (9) exhibited an overall
significant (16–21mm) activity against all strains except S. typhi
which possessed low to moderate (11–13mm) activity. Rest of the
complexes (5), (8) and (11) demonstrated significant (16–24mm)
activity against all bacterial strains except E. coli, which showed
moderate (10–13mm) activity. The data depicted in Table 3 clearly
indicates that (L3) exhibited overall good bacterial activity as com-
pared to the other three ligands. The Ni(II) complex (6) of (L2) was
found to be the most active complex. The metal(II) complexes
showed33 higher activity results upon chelation rather than their
non-coordinated Schiff bases.
Antifungal activity (in vitro)
The newly synthesized compounds were screened for antifungal
activity against Trichophytonlongifusus, Candida albicans (C. albi-
cans), Aspergillus flavus (A. flavus), Microsporum canis (M. canis),
Fusarium solani (F. solani) and Candida glabrata (C. glabrata) fungal
strains Table 4 according to the available protocols in the relevant
literature17. The obtained results in percentage inhibition were
compared with the results obtained from standard drugs, micona-
zole and amphotericin B. The ligand (L1) displayed significant
(57%) activity against Trichophytonlongifusus fungal strain, moder-
ate (38–50%) activity against C. albicans, A. flavus, M. canis and
F. solani but showed weaker (31%) activity against C. albicans.
Moreover, the ligand (L2) exhibited significant (56–60%) activity
against C. albicans and Fusarium solani, moderate (38–41%) activity
against Trichophytonlongifusus, A. flavus and C. glabrata but
complete lack of activity against M. canis. Furthermore, the
ligand (L3) possessed moderate (36–51%) activity against
Trichophytonlongifusus, C. albicans, M. canis and F. solani and inter-
estingly demonstrated inactivity against the remaining strains. The
metal complexes (1)–(4) exhibited overall significant (55–74%)
activity against all the fungal strains. Similarly, the complex (5)–(8)
displayed significant (55–75%) activity against all the strains except
M. canis where they showed low (20–31%) activity. The com-
pounds (9)–(12) demonstrated significant (55–78%) activity against
Trichophytonlongifusus, C. albicans, M. canis and Fusarium solani,
moderate (35–42%) against A. flavus and weaker (17–31%) activity
Table 4. Antifungal activity of ligands (L1)–(L3) and metal(II) complexes (1)–(12).
[% Inhibition (mm)]
Compounds (a) (b) (c) (d) (e) (f) (SA) Average
(L1) 57 40 45 50 38 31 8.42 43.50
(L2) 41 60 39 00 56 38 19.39 39.00
(L3) 36 44 00 46 51 00 21.32 29.50
(1) 74 62 67 62 60 56 5.71 63.50
(2) 68 55 59 65 61 59 4.26 61.17
(3) 71 59 56 71 59 58 6.21 62.33
(4) 69 66 70 62 57 60 4.73 64.00
(5) 60 75 61 29 69 57 14.51 58.50
(6) 56 67 57 20 74 61 17.16 55.83
(7) 65 76 60 31 61 55 13.69 58.00
(8) 68 72 58 29 70 62 14.58 59.83
(9) 59 57 42 70 78 27 16.95 55.50
(10) 55 60 35 71 71 17 19.61 51.50
(11) 66 64 40 60 62 31 13.35 53.83
(12) 60 58 38 58 69 30 13.57 52.17
SD A B C D E F – –
Average activity of ligands (L1)–(L3)¼ 37.33%; average activity of complexes
(1)–(12)¼ 58.01%; (a) T. longifusus, (b)¼ C. albicans, (c)¼ A. flavus, (d)¼M. canis,
(e)¼ F. solani and (f)¼ C. glabrata; SD: standard drugs; MIC lg/mL;
A¼miconazole (70 lg/mL: 1.6822 107 M/mL), B¼miconazole (110.8lg/mL:
2.6626 107 M/mL), C¼ amphotericin B (20 lg/mL:2.1642 108 M/mL),
D¼miconazole (98.4 lg/mL: 2.3647 107 M/mL), E¼miconazole (73.25lg/mL:
1.7603 107 M/mL) and F¼miconazole (110.8lg/mL: 2.66 266 107 M/mL);
weaker¼ 0–33%; moderate¼ 34–54%; 55–100%¼ significant; SA: statistical
analysis.
Table 3. Antibacterial activity of ligands (L1)–(L3) and metal(II) complexes (1)–(12).
[Zone of inhibition (mm)]
Gram-negative Gram-positive
Compounds (a) (b) (c) (d) (e) (f) (SA) Average
(L1) 10 13 12 16 10 16 2.71 12.83
(L2) 11 10 13 09 09 12 1.63 10.67
(L3) 13 16 15 19 08 09 3.66 13.33
(1) 23 18 19 18 20 17 2.14 19.17
(2) 20 21 11 18 19 21 3.78 18.33
(3) 18 16 20 21 19 17 1.87 18.50
(4) 19 21 18 23 17 16 2.61 19.00
(5) 10 20 24 21 18 17 4.35 18.33
(6) 19 20 24 17 23 16 3.19 19.83
(7) 20 19 12 16 18 19 2.94 17.33
(8) 12 16 20 21 24 18 4.18 18.50
(9) 21 18 13 20 14 19 3.28 17.50
(10) 16 21 18 17 25 19 3.27 19.33
(11) 13 16 19 20 23 24 4.17 19.17
(12) 18 24 17 20 21 17 2.74 19.50
SD 25 26 25 26 27 28 1.07 26.17
Average activity of ligand (L1)–(L3)¼ 12.28mm; average activity of complexes
(1)–(12)¼18.71mm; (a) E. coli, (b) P. aeruginosa, (c) S. typhi, (d) S. flexneri, (e) S.
aureus and (f) B. subtilis; SD: standard drug (imipenem); weaker¼ 0–09mm;
moderate¼ 10–15mm; above 16mm¼ significant; SA: statistical analysis.
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against C. glabrata. It is obvious from the data reported in Table 4
that ligand (L1) displayed overall good fungal activity as compared
to the other three ligands. The Zn(II) complex (4) of (L1) was
found to be the most active complex. The metal(II) complexes
showed enhanced34 activity results compared to their non-coordi-
nated Schiff bases upon complexation (Figure 2).
Minimum inhibitory concentration (MIC)
The transition metal(II) complexes which displayed promising anti-
bacterial activity (more than 80%) were selected for MIC studies
and results are presented in Table 5. MIC values of the metal com-
plexes fell in the range of 18.42–39.91 lg/mL. Amongst these, the
complex (1) was found to be the most active possessing max-
imum inhibition 18.42lg/mL against bacterial strain E. coli.
Conclusions
The newly synthesized Schiff bases acted as tridentate ligands for
chelation with the Co(II), Cu(II), Ni(II) and Zn(II) metal atoms.
Physical (magnetic and molar conductance), spectral (IR, NMR and
electronic) and analytical (C, H, N, Co, Cu, Ni and Zn%) data estab-
lished that the Schiff base ligands are coordinated with the metal
ions through azomethine-N, thienyl-S and ammine-N presenting
an octahedral geometry. The obtained results of antibacterial and
antifungal activities revealed that the metal complexes are found
to be more biological active against one or more bacterial and/or
fungal strains as compared to their parent non-coordinated Schiff
base ligands. Usually, it is claimed that the functional groups like
azomethine-N, thienyl-S and ammine-N present in the compounds
are responsible for the enhancement of bacterial and fungal activ-
ities. These findings propose that the synthesized metal-based
compounds have the potential to be developed therapeutic
agents.
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